GLP-1 RECEPTOR AGONISTS IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE: THERAPEUTIC POTENTIAL AND CLINICAL CHALLENGES. IJITSS. 2025;1(3(47). doi:10.31435/ijitss.3(47).2025.3493